We are live on
!
Find out more
CAM
Congress Asset Management Portfolio holdings
AUM
$16.3B
1-Year Est. Return
42.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.34%
1 Year Est. Return
+42.69%
3 Year Est. Return
+133.81%
5 Year Est. Return
+171.24%
10 Year Est. Return
+841.07%
AUM
$7.26B
AUM Growth
+$156M
(+2.2%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
15.49%
Holding
392
New
14
Increased
131
Reduced
191
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$82.8M |
| 2 |
Littelfuse
LFUS
|
+$80M |
| 3 |
Xylem
XYL
|
+$79.1M |
| 4 |
Qualys
QLYS
|
+$67.6M |
| 5 |
Cisco
CSCO
|
+$51.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBM
Cambrex Corporation
CBM
|
+$86.2M |
| 2 |
Masco
MAS
|
+$80.6M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$78.6M |
| 4 |
Electronic Arts
EA
|
+$60.8M |
| 5 |
RPC Inc
RES
|
+$60.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.76% |
| 2 | Industrials | 18.41% |
| 3 | Healthcare | 15.96% |
| 4 | Consumer Discretionary | 15.23% |
| 5 | Financials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
L3Harris
LHX
$55.4B
| $5.95M | 0.08% |
41,159
-3,822
| -8% | -$592K |
|
152
Gentex
GNTX
$5.1B
| $5.83M | 0.08% |
253,288
-28,213
| -10% | -$669K |
|
153
State Street SPDR Dow Jones REIT ETF
RWR
$1.9B
| $5.81M | 0.08% |
61,794
-229
| -0.4% | -$20.4K |
|
154
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $5.78M | 0.08% |
147,570
-1,270
| -0.9% | -$51K |
|
155
Interparfums
IPAR
$4.07B
| $5.78M | 0.08% |
107,942
+3,373
| +3% | +$172K |
|
156
3M
MMM
$91.8B
| $5.73M | 0.08% |
34,812
+537
| +2% | +$91.6K |
|
157
CEVA Inc
CEVA
$831M
| $5.69M | 0.08% |
188,502
-1,963
| -1% | -$66.3K |
|
158
Occidental Petroleum
OXY
$55.7B
| $5.55M | 0.08% |
66,304
+3,170
| +5% | +$253K |
|
159
Colgate-Palmolive
CL
$74.8B
| $5.53M | 0.08% |
85,367
-2,380
| -3% | -$156K |
|
160
Merck
MRK
$322B
| $5.43M | 0.07% |
93,791
-5,446
| -5% | -$307K |
|
|
BCPC
161
Balchem Corp
BCPC
$5.26B
| $5.41M | 0.07% |
55,138
+1,832
| +3% | +$171K |
|
162
RPM International
RPM
$13.8B
| $5.34M | 0.07% |
91,490
+6,321
| +7% | +$317K |
|
|
EBIX
163
DELISTED
Ebix Inc
EBIX
| $5.27M | 0.07% |
69,152
-1,950
| -3% | -$150K |
|
|
ALXN
164
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.26M | 0.07% |
42,367
-4,411
| -9% | -$516K |
|
|
PDCE
165
DELISTED
PDC Energy, Inc.
PDCE
| $5.24M | 0.07% |
86,721
-2,790
| -3% | -$161K |
|
|
CADE
166
DELISTED
Cadence Bank
CADE
| $5.22M | 0.07% |
158,456
-4,870
| -3% | -$163K |
|
167
SPX Corp
SPXC
$9.39B
| $5.2M | 0.07% |
148,455
-4,970
| -3% | -$169K |
|
168
Eaton
ETN
$141B
| $5.16M | 0.07% |
69,024
-8,099
| -11% | -$626K |
|
|
WNS
169
DELISTED
WNS Holdings
WNS
| $5.14M | 0.07% |
98,432
+18,490
| +23% | +$913K |
|
|
BIG
170
DELISTED
Big Lots, Inc.
BIG
| $5.12M | 0.07% |
122,623
+77,735
| +173% | +$3.26M |
|
171
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1B
| $5.01M | 0.07% |
279,994
+9,850
| +4% | +$171K |
|
|
MBFI
172
DELISTED
MB Financial Corp
MBFI
| $5M | 0.07% |
107,043
-3,200
| -3% | -$146K |
|
173
Trimble
TRMB
$13.6B
| $4.99M | 0.07% |
151,960
+3,473
| +2% | +$120K |
|
174
TE Connectivity
TEL
$60B
| $4.93M | 0.07% |
54,770
+2,636
| +5% | +$252K |
|
175
Thor Industries
THO
$4.06B
| $4.91M | 0.07% |
50,427
+5,449
| +12% | +$556K |
|
Similar funds
UCFA
LCOV
CCMG
IG
EIP
CI
AIMCA
Congress Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, Congress Asset Management held 392 positions worth $7.26B, up 2.2% from $7.11B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Congress Asset Management's Q2 2018 filing shows 14 new, 131 increased, 191 reduced and 25 closed positions. Its largest new stake was Jazz Pharmaceuticals: 506,535 shares worth $87.3M. The largest sale was Cambrex Corporation, an estimated $86.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Congress Asset Management's largest Q2 2018 buy was Jazz Pharmaceuticals: 506,535 shares worth $87.3M.
- Congress Asset Management added most to Littelfuse in Q2 2018, an estimated $80M increase.
- Congress Asset Management's biggest Q2 2018 reduction was Masco, cutting an estimated $80.6M.
- Congress Asset Management fully exited Cambrex Corporation in Q2 2018, selling an estimated $86.2M.
- Congress Asset Management's ten largest holdings make up 15% of its $7.26B portfolio in Q2 2018.
- Congress Asset Management opened 14 new positions and closed 25 in Q2 2018.
- Congress Asset Management's portfolio value rose 2.2% quarter-over-quarter to $7.26B.
Based on Congress Asset Management's 13F filing for Q2 2018, filed 25 Jul 2018.